Clinical Study Protocol
This clinical trial protocol outlines a study to test YTS109 cells in patients with treatment-resistant autoimmune diseases like lupus, Sjögren's syndrome, and vasculitis. The protocol details the study design, dosage, patient criteria, and endpoints for assessing both safety and effectiveness.